Position in MRVI
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,370,387
-$326,249 QoQ
Shares Held
484,236
-7.2% QoQ
Ownership
0.188%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,428,056,604 across 399 Biotechnology names. MRVI ranks #72 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,370,387 | 484,236 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,696,636 | 522,042 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $925,235 | 322,382 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $593,369 | 246,212 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $200,027 | 90,511 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $635,991 | 116,696 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $919,165 | 110,610 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $415,493 | 58,030 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $1,741,090 | 200,818 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $482,654 | 73,688 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,815,660 | 181,566 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $29,096,886 | 2,340,860 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $33,974,500 | 2,425,018 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $26,425,916 | 1,846,675 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $51,998,326 | 2,036,754 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $42,772,417 | 1,505,541 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $53,794,577 | 1,525,222 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $53,529,552 | 1,277,555 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $43,407,429 | 884,422 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $2,219,408 | 53,185 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $288,398 | 8,092 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $18,709 | 667 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||